Latest Period
Q1 2026
Security Snapshot
Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) Institutional Ownership
CUSIP: 45783C200
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026
Institutions Reporting
31
Shares (Excl. Options)
2,297,605
Price
$8.24
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $ 0.000001 per share
- Symbol
- TIL on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 2,297,605
- Total 13F value
- $18,932,177
- Portfolio coverage rank
- 0%
- Share change
- -253,818
- Value change
- -$2,815,187
- Number of holders
- 31
- Shares outstanding
- 6,505,400
- SEC-reported price per share
- $8.02
- Insider filing price
- $8.02
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TIL - Instil Bio, Inc. - Common stock, par value $ 0.000001 per share is tracked under CUSIP 45783C200.
- 31 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 28 to 31 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $27,981,700 to $18,932,177.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 31 institutions filings for Q1 2026.
Security key
45783C200
Latest holder period
Q1 2026
13F holders
31
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
TIL full holder history
Instil Bio, Inc. SEC filings
Instil Bio, Inc. company facts
Instil Bio, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45783C200:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
TIL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital IX, LLC | 4.5% | $7,169,276 | 292,743 | Vivo Capital IX, LLC | 30 Jun 2025 |
As of 31 Mar 2026, 31 institutional investors reported holding 2,297,605 shares of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL). This represents 35% of the company’s total 6,505,400 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
35%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 9.9% | 645,600 | 0% | 3.4% | $5,319,744 |
| CPMG Inc | 6.3% | 410,922 | 0% | 9.1% | $3,385,997 |
| Vivo Capital, LLC | 4.5% | 292,743 | 0% | 0.2% | $2,412,202 |
| Kalehua Capital Management LLC | 2.8% | 183,030 | 1.1% | $1,508,167 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.7% | 174,583 | 0% | 0% | $1,438,564 |
| MILLENNIUM MANAGEMENT LLC | 2% | 132,946 | -45% | 0% | $1,095,475 |
| RENAISSANCE TECHNOLOGIES LLC | 0.91% | 59,100 | -13% | 0% | $486,984 |
| BlackRock, Inc. | 0.8% | 52,018 | +1.6% | 0% | $428,628 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 0.77% | 50,000 | 0% | 0% | $412,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.75% | 49,011 | +15% | 0% | $403,995 |
| CITADEL ADVISORS LLC | 0.59% | 38,562 | -19% | 0% | $317,751 |
| LPL Financial LLC | 0.49% | 32,063 | -3.1% | 0% | $264,199 |
| XTX Topco Ltd | 0.4% | 26,242 | +114% | 0% | $216,234 |
| VANGUARD FIDUCIARY TRUST CO | 0.35% | 22,625 | 0% | 0% | $186,430 |
| DIMENSIONAL FUND ADVISORS LP | 0.31% | 19,975 | -67% | 0% | $164,470 |
| MORGAN STANLEY | 0.3% | 19,821 | -78% | 0% | $163,325 |
| STATE STREET CORP | 0.27% | 17,595 | 0% | 0% | $144,983 |
| Americana Partners, LLC | 0.25% | 16,176 | 0% | 0% | $133,290 |
| JANE STREET GROUP, LLC | 0.18% | 11,517 | 0% | $94,901 | |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.16% | 10,300 | 0.01% | $84,872 | |
| Vazirani Asset Management LLC | 0.15% | 10,000 | 0.19% | $82,400 | |
| FNY Investment Advisers, LLC | 0.15% | 10,000 | 0.04% | $82,000 | |
| UBS Group AG | 0.1% | 6,378 | +1677% | 0% | $52,554 |
| BARCLAYS PLC | 0.06% | 4,135 | -59% | 0% | $34,072 |
| Vanguard Global Advisers, LLC | 0.02% | 1,470 | 0% | 0% | $12,113 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q1 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,297,605 | $18,932,177 | -$2,815,187 | $8.24 | 31 |
| 2025 Q4 | 2,543,805 | $27,981,700 | -$4,191,273 | $11.00 | 28 |
| 2025 Q3 | 2,655,269 | $47,423,593 | -$2,963,439 | $17.86 | 33 |
| 2025 Q2 | 2,751,266 | $57,311,087 | -$11,020,093 | $20.83 | 37 |
| 2025 Q1 | 3,353,462 | $58,216,200 | -$97,479 | $17.36 | 42 |
| 2024 Q4 | 3,339,375 | $63,749,218 | -$66,077,020 | $19.09 | 39 |
| 2024 Q3 | 3,419,403 | $230,187,844 | +$81,138,546 | $67.32 | 48 |
| 2024 Q2 | 2,328,646 | $23,960,769 | -$220,805 | $10.29 | 29 |
| 2024 Q1 | 2,348,572 | $25,363,318 | +$3,416,073 | $10.80 | 30 |
| 2023 Q4 | 2,037,306 | $15,523,621 | +$13,556,922 | $7.62 | 27 |